News and Press Releases
Novonesis expands global footprint with acquisition of production facility in Southeast Asia
Investment of around USD 50 million strengthens fermentation capabilities and supports the company’s long-term growth ambitions 8 April 2026 -- Copenhagen, Denmark -- Novonesis has signed an agreement with Meihua to...
Category: Manufacturing and Packing, Other, Pharmaceutical
Posted: April 8, 2026
BRAIN Biotech has been granted a key patent for its CRISPR-BMC genome-editing technology
Newly patented CRISPR nuclease exhibits high activity in various prokaryotic and eukaryotic organismsPatent now opens up significant potential for further commercial use through licensing BRAIN Biotech offers its technology for...
Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: March 23, 2026
Codexis signs agreement to manufacture 50g siRNA using its ECO Synthesis Manufacturing Platform
4 March 2026 -- California, US -- Codexis, Inc, a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced it has entered into an agreement with...
Category: BioManufacturing, Drug Discovery, Other, Pharmaceutical
Posted: March 4, 2026
BRAIN Biotech announces 3M 25/26 results and breakthrough at BioIncubator company SolasCure
Aurase Wound Gel showing strong clinical evidence of superior debridement and healing in chronic wounds Aurase shows dual action on chronic wound debridement and healing SolasCure preparing fund raising for...
Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: February 25, 2026
SolasCure completes phase II clinical trial, demonstrating accelerated healing with Aurase Wound Gel
Aurase Wound Gel shows 22x faster debridement and 7x faster healing compared to standard of care in sloughy venous leg ulcers, supporting advancement to the next phase of development Data...
Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: February 24, 2026
EsoCap to Present Key Phase II Results on Novel Drug Delivery System in Eosinophilic Esophagitis at DDW 2025
New insights on safety, adherence, and patient satisfaction with ESO-101 to be presented on May 3, 2025, at DDW 2025 ESO-101 features EsoCap’s proprietary drug delivery technology to enable localized...
Category: Biotechnology, Clinical Trials, Drug Delivery, Drug Discovery, Pharmaceutical
Posted: April 22, 2025
Novonesis probiotic strain receives health claim in Canada
Health Canada authorizes functional claims that the new probiotic strain CLEPIUS™ “helps alleviate perceived stress and improve irritable bowel syndrome-related quality of life in adults” 11 March 2024 -- Copenhagen,...
Category: Biotechnology, Other, Pharmaceutical
Posted: March 11, 2025
PureTech Founded Vedanta Biosciences Publishes Additional Phase 2 VE303 Results in Nature Medicine
VE303 was well tolerated and decreased the odds of rCDI through multiple mechanisms Analyses identified predictors of VE303 colonization and protection from CDI recurrence Topline data for the ongoing Phase...
Category: Biotechnology, Clinical Trials, Drug Discovery, Other
Posted: January 23, 2025
